MWM
GILD icon

Mission Wealth Management’s Gilead Sciences GILD Stock Holding History

Mission Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,000
Closed -$438K – 317
2018
Q4 		$438K Buy
+7,000
New +$489K 0.06% 165

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Mission Wealth Management's GILD Position: Q2 2026 in Review

Mission Wealth Management increased its Gilead Sciences (GILD) stake by 46% in Q2 2026, buying an estimated $701K and bringing the position to 16,879 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #296.

Mission Wealth Management first reported a position in GILD in Q2 2015 and has held it in 45 quarters since. The position peaked at $3.06M in Q3 2019. 992 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mission Wealth Management held 16,879 shares of Gilead Sciences worth $2.13M as of Q2 2026.
  • Mission Wealth Management bought 5,320 Gilead Sciences shares in Q2 2026, an estimated $701K.
  • Gilead Sciences made up 0.03% of Mission Wealth Management's portfolio in Q2 2026, its #296 holding.
  • Mission Wealth Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 45 quarters since.
  • Mission Wealth Management's Gilead Sciences position peaked at $3.06M in Q3 2019.
  • 992 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.